Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

Contraception
S KoetsawangE S Kononova

Abstract

A multicentre clinical trial, including 19 centres in 13 countries, assessed the contraceptive efficacy and clinical acceptability of a Silastic 382 vaginal ring releasing 20 micrograms of levonorgestrel for at least 90 days. A total of 1005 women entered the study and 8176.74 woman-months of experience was gathered. The rate of intrauterine pregnancy at one year of use was 3.6 per 100 women (95% confidence interval 2.2-5.0), and of ectopic pregnancy, 0.2% (one case). The principal reasons for discontinuation were menstrual disturbances (17.2% at one year), vaginal symptoms (6.0%) and repeated expulsion of the ring (7.1%). The pregnancy rate with this 20 micrograms levonorgestrel-releasing vaginal ring compares favourably with that of a low estrogen combination oral contraceptive tested by WHO and is less than half that of a progestogen-only oral contraceptive in a WHO randomized study. It is concluded that the WHO intravaginal ring releasing an average of 20 micrograms of levonorgestrel per 24 hours is an effective method of contraception for at least one year of use.

Citations

May 27, 1993·The New England Journal of Medicine·D T Baird, A F Glasier
Jun 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·I C ChiS Balogh
Nov 22, 2005·Expert Opinion on Drug Delivery·Regine Sitruk-Ware
Jun 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·E M Belsey
Jul 21, 2020·Expert Opinion on Drug Delivery·Peter BoydR Karl Malcolm
Feb 1, 1991·Statistics in Medicine·E M Belsey, N Carlson
Apr 1, 1993·Annals of Medicine·D R Mishell
May 1, 1994·Journal of the American Academy of Nurse Practitioners·J WalthallM H Hutti
Dec 1, 1996·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M Bygdeman
Feb 24, 2001·Clinical Obstetrics and Gynecology·S A Ballagh
Nov 17, 2007·Current Opinion in Obstetrics & Gynecology·Risto Erkkola
Sep 23, 2008·Expert Review of Medical Devices·Giuseppe BenagianoManuela Farris
Oct 6, 2018·Expert Opinion on Pharmacotherapy·Ilza MonteiroLuis Bahamondes
Mar 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·X F LiJ Newton
Dec 12, 2012·International Urogynecology Journal·Sushma Srikrishna, Linda Cardozo
Aug 13, 2011·Infectious Diseases in Obstetrics and Gynecology·Andrea Ries ThurmanGustavo F Doncel
Aug 19, 2016·The Cochrane Database of Systematic Reviews·Laureen M LopezFrans M Helmerhorst
Feb 18, 2005·Acta Obstetricia Et Gynecologica Scandinavica·Risto Erkkola, Britt-Marie Landgren
Jul 20, 2021·Geburtshilfe und Frauenheilkunde·Fojan RafieiKhosrow Mottaghy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.